What does CUSIP 55279B202 represent in this 13F holders report?

CUSIP 55279B202 is the security identifier for MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value used to aggregate holder disclosures.

How many institutions held MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value in Q1 2016?

36 institutional investors reported MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value for Q1 2016. Use the holders table for investor-level position and value details.

MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP)

CUSIP: 55279B202

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class: Equity / Common Stock, $0.00000002 par value
Shares outstanding: 29,545,622
Total 13F shares: 9,938,127
Share change: +560,786
Total reported value: $12,522,000
Put/Call ratio: 0%
Price per share: $1.26
Number of holders: 36
Value change: +$584,155
Number of buys: 10
Number of sells: 17

Security key

55279B202

Report period

Q1 2016

Institutions

Top holders

MEIP full security history Newer quarter: Q2 2016 Previous quarter: Q4 2015 Lite Strategy, Inc. SEC filings Lite Strategy, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 55279B202

Newer quarter: Q2 2016 Previous quarter: Q4 2015

Recent filing periods:

Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021

Top shareholders of MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Anson Funds Management LP	13F	Company	6.6%	1,944,479	$3,111,000	—	31 Dec 2015	13F
VANGUARD GROUP INC	13F	Company	3.4%	990,401	$1,585,000	—	31 Dec 2015	13F
Ancora Advisors LLC	13F	Company	1.6%	475,000	$760,000	—	31 Dec 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.4%	422,779	$676,000	—	31 Dec 2015	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	1.4%	404,975	$648,000	—	31 Dec 2015	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	1.3%	390,000	$624,000	—	31 Dec 2015	13F
FMR LLC	13F	Company	1.1%	334,697	$536,000	—	31 Dec 2015	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.93%	275,300	$440,000	—	31 Dec 2015	13F
WASATCH ADVISORS LP	13F	Company	0.89%	261,976	$419,000	—	31 Dec 2015	13F
SABBY MANAGEMENT, LLC	13F	Company	0.68%	200,000	$320,000	—	31 Dec 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.43%	127,975	$204,000	—	31 Dec 2015	13F
A.R.T. Advisors, LLC	13F	Company	0.43%	127,176	$203,000	—	31 Dec 2015	13F
TFS CAPITAL LLC	13F	Company	0.27%	79,349	$127,000	—	31 Dec 2015	13F
BlackRock Fund Advisors	13F	Company	0.26%	78,163	$125,000	—	31 Dec 2015	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.22%	63,549	$102,000	—	31 Dec 2015	13F
KEYBANK NATIONAL ASSOCIATION/OH	13F	Company	0.2%	57,642	$92,000	—	31 Dec 2015	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.18%	52,301	$84,000	—	31 Dec 2015	13F
NORTHERN TRUST CORP	13F	Company	0.12%	35,429	$57,000	—	31 Dec 2015	13F
Carnick & Kubik, LLC	13F	Company	0.1%	30,355	$49,000	—	31 Dec 2015	13F
MORGAN STANLEY	13F	Company	0.1%	29,939	$48,000	—	31 Dec 2015	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.1%	29,392	$47,000	—	31 Dec 2015	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.1%	28,209	$45,000	—	31 Dec 2015	13F
Bank of New York Mellon Corp	13F	Company	0.09%	27,344	$44,000	—	31 Dec 2015	13F
CITADEL ADVISORS LLC	13F	Company	0.09%	25,268	$40,000	—	31 Dec 2015	13F
Cutler Group LLC / CA	13F	Company	0.06%	17,621	$28,000	—	31 Dec 2015	13F
Stevens First Principles Investment Advisors	13F	Company	0.05%	16,000	$26,000	—	31 Dec 2015	13F
Rotella Capital Management, Inc.	13F	Company	0.05%	14,074	$23,000	—	31 Dec 2015	13F
Virtu KCG Holdings LLC	13F	Company	0.05%	13,934	$22,000	—	31 Dec 2015	13F
Gilman Hill Asset Management, LLC	13F	Company	0.05%	13,316	$21,000	—	31 Dec 2015	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.03%	8,620	$14,000	—	31 Dec 2015	13F
BLACKROCK ADVISORS LLC	13F	Company	0.03%	8,459	$14,000	—	31 Dec 2015	13F
BlackRock Investment Management, LLC	13F	Company	0.02%	5,628	$9,000	—	31 Dec 2015	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	3,700	$6,000	—	31 Dec 2015	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	2,500	$4,000	—	31 Dec 2015	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	2,287	$4,000	—	31 Dec 2015	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	0.01%	1,500	$2,000	—	31 Dec 2015	13F
Creative Planning	13F	Company	0%	1,242	$2,000	—	31 Dec 2015	13F
UBS Group AG	13F	Company	0%	1,008	$2,000	—	31 Dec 2015	13F

Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q1 2016

As of 31 Mar 2016, MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,938,127 shares. The largest 10 holders included Vivo Capital, LLC, Frigate Ventures LP, VANGUARD GROUP INC, Ancora Advisors, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Institutional Trust Company, N.A., Connor, Clark & Lunn Investment Management Ltd., BRIDGEWAY CAPITAL MANAGEMENT INC, FMR LLC, and WASATCH ADVISORS INC. This page lists 36 institutional shareholders reporting positions in this security for the Q1 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2016 vs Q4 2015 Across Filers

Q4 2015 holders

Q1 2016 holders

Holder diff

-1

Investor	Q4 2015 Shares	Q1 2016 Shares	Share Diff	Share Chg %	Q4 2015 Value $	Q1 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.